Orthopedics and General Medical Devices

Format: 2016-08-26
Format: 2016-08-26
August 26, 2016 | 60 Pages | SKU: IRTNTR10089

Outlook of the surgical power tools market

Extensive research carried out by the analysts at Technavio has shown that the global surgical power tools market will witness steady growth and will post a moderate CAGR of more than 3% over the forecast period. With the increasing adoption of battery-driven cordless surgical power tools, this market is anticipated to have a positive outlook in the coming years. The use of Li-ion batteries in surgical tools greatly improves the workflow efficiency of surgeons as these batteries offer greater energy density, improved reliability, longer life cycle, and higher performance. Moreover, the rapid technological advancements and increasing market competition have driven the vendors to offer more of battery-powered surgical instruments in their product portfolios. The companies are focusing on developing powered surgical instruments that are lighter in size and ergonomically designed. Furthermore, while the conventional surgical tools have limitations in sterilization methods, battery-powered surgical tools can be sterilized by various methods such as hydrogen peroxide gases, ethylene oxide gases, and gamma rays.

The advent of robotic surgery is one of the significant trends that is expected to fuel the demand for surgical power tools during the predicted period. The surgical tools are integrated with robots that perform various procedures including minimally invasive surgeries. In addition, most surgical robots work with multi-arms, thereby increasing the demand for various surgical power tools. For instance, the University of Washington has developed a surgical robot that can use multiple surgical tools during operations. Surgical robots are self-powered,


August 09, 2016 | 61 Pages | SKU: IRTNTR10133

Overview of the global craniomaxillofacial (CMF) devices market

Technavio’s market research analysts have estimated that the global craniomaxillofacial (CMF) devices market will grow steadily at a CAGR of over 6% by 2020. According to this market research, an important factor leading to the strong growth of this market is the development of effective 3D implants. In recent years, innovations in instrumentation and imaging technology have led to advancements in endoscopic skull base surgery techniques. Since skull base reconstruction of endonasal defects still poses a huge challenge for therapists, the need for vascularized flaps for endonasal reconstruction has increased as it helps to improve the outcome. Additionally, as the use of 3D implants significantly reduces unnecessary surgical revisions, the need for additional surgical expenses will reduce drastically.

The global market for CMF devices is dominated by the Americas, which singlehandedly accounted for approximately 52% of the total market share during 2015. Among all regions in the Americas, North America accounted for the largest share of the market owing to the growth in the number of CMF procedures and the adoption of patient-specific cranial implants.  Furthermore, with the introduction of various materials with better stability and biocompatibility, the product safety of biomaterials has increased. In addition, the focus on developing bioresorbable CMF fixators will also aid in the growth of this market in the Americas during the estimated period.

Competitive landscape and key vendors

The global


August 01, 2016 | 109 Pages | SKU: IRTNTR10184

Overview of the global negative pressure wound therapy (NPWT) market

Market research analysts at Technavio predict that the global negative pressure wound therapy (NPWT) market will grow progressively at a moderate CAGR of approximately 8% by 2020. One of the factors that will drive the market will be the emergence of hospitals with advanced wound care services. A large number of hospitals are investing in the training and acquisition of skilled professional healthcare staffs such as physicians and nurses, which will have a positive impact on wound care management and its services. For instance, Healogics recently acquired Accelecare, which provides full-service wound management solutions to around 140 hospitals and formed a partnership with local hospitals for skilled nursing facilities and caring services for individuals.

The market analyst predicts that the Americas will be the largest market for NPWT and will grow steadily during the forecast period at a moderate CAGR of approximately 7%. Changes in the healthcare sector such as the reduction of unnecessary readmissions to hospitals and the recent increase in availability of optimum quality products will improve the quality of life for patients, which, in turn, will augment the prospects for market growth. Additionally, many vendors in the market will also be investing in research and development of cost-effective products as it will help them to reach a wider customer base.

Competitive landscape and key vendors

The market appears fragmented due to the presence of numerous large, medium, and small-sized companies. The implementation of aggressive pricing, product differentiation, capital support for product, technology advancement, and distribution partnerships will increase the level of competition during the estimated period.

Key vendors in the market are -

  • Acelity

August 01, 2016 | 62 Pages | SKU: IRTNTR10068

Overview of the global spinal cord stimulation (SCS) devices market

Technavio’s market research analyst predicts the global spinal cord stimulation (SCS) devices market to grow steadily at a CAGR of around 4% by 2020. Global exposure and availability of several innovative techniques for learning have prompted surgeons to increase their knowledge about SCS devices. Several pain management societies are spreading awareness about SCS devices through international conferences, annual meetings, seminars, and workshops. Hospitals are actively participating in promoting these devices by educating patients on the necessity of using these devices for better health. Moreover, the growing shift towards minimally invasive surgery (MIS) is another development triggering the use of SCS devices. These surgeries are less painful, reduce the operative traumatic stress, and help patients to recover faster. The use of MIS techniques to treat spine-related disorders is likely to increase in the coming years, propelling the use of SCS devices.

The Americas is the largest revenue-contributing region in the SCS devices market and is anticipated to occupy around 59% of the overall market revenue during the forecast period. Much of the region’s growth is likely to come from the high investments by top manufacturers to improve product compatibility and patient safety. Majority of the region’s revenue comes from the US due to technological advancements and the availability of reimbursement facilities in the country. With the growing preference for SCS devices by the surgeons' in MIS technique for chronic back pain management, the market will witness huge growth in


July 28, 2016 | 60 Pages | SKU: IRTNTR8494

Outlook of the global non-invasive fat reduction devices market

Technavio’s market research analyst predicts the global non-invasive fat reduction devices market to grow at an impressive CAGR of around 27% during the forecast period. The increasing adoption of non-invasive cosmetic procedures is the primary growth driver for this market. Recently, it has been observed that many consumers prefer non-invasive procedures since it offers less side effects and complications when compared to traditional procedures. This paradigm shift in the consumers’ preference will aid in the growth of this market during the predicted period. Furthermore, with an increase in the number of professional cosmetic surgeons and beauty clinics across the globe, the market for non-invasive fat reduction devices will have a positive outlook during the next few years.

Geographical segmentation of the non-invasive fat reduction devices market

  • Americas
  • APAC
  • EMEA

In this market analysis, Technavio’s market research analyst has estimated the Americas to be the largest market for non-invasive fat reduction devices procedures during the forecast period. This region currently dominates this market and is envisaged to grow at an impressive CAGR of around 26% during the forecast period. Factors such as the recent increase in the number of new product approvals by the FDA, increase in beauty consciousness, and the recent rise in disposable income will foster market growth in this region during the predicted period.

Competitive landscape and key vendors

The global non-invasive fat reduction devices market is highly competitive owing to the presence of many large vendors that account for a substantial market share. The vendors in this market are also establishing state-of-the-art research facilities to develop new products and are also expanding their operations


July 28, 2016 | 47 Pages | SKU: IRTNTR8281

Market outlook of global renal denervation

Technavio’s market research analyst predicts the global renal denervation (RD) market to account for a CAGR of almost 12% during the forecast period. One of the primary drivers for the growth of the market is the growing prevalence of hypertension. Unhealthy dietary habits, stress, and lack of physical exercise due to hectic lifestyles are common risk factors for hypertension, hypercholesterolemia, coronary heart diseases, and diabetes. Following the increased prevalence of hypertension among people, the demand for RD procedures has also increased, thereby, leading to the growth of the renal denervation market.

The adoption of minimally invasive catheter-based endovascular procedure is another major factor leading to the growth of the market. Minimally invasive and localized nature procedure has increased the adoption of renal denervation devices as these devices are safe, effective, and reduce cardiometabolic risk. Additionally, the recent expansion of minimally invasive endovascular procedures had led to the development of a radio-frequency catheter-based approach for renal denervation.

Geographical segmentation and analysis of the renal denervation market

  • Europe
  • Rest of the world

Europe was the biggest market for renal denervation and accounted for a share of more than 57% of the overall market in 2015. Countries such as Germany, France, the UK, and Italy in Europe were the largest revenue contributors in the global renal denervation devices market. Some of the major factors supporting the growth of the market are the increase in the number of cases of drug-resistant hypertension and technological advancements.

Competitive landscape and key vendors

The vendors in the renal denervation market are developing


Pages